STOCKWATCH
·
Pharmaceuticals
Board Meeting24 Mar 2026, 07:41 pm

Aptus Pharma Ltd. Announces 3:2 Bonus Issue and Increase in Authorized Share Capital

AI Summary

Aptus Pharma Ltd. held a Board Meeting on March 24, 2026, where they approved several key decisions. The company proposed an increase in its authorized share capital from INR. 7,15,00,000/- to INR 25,00,00,000/-. Additionally, the Board recommended a bonus issue of equity shares in the ratio of 3:2, subject to the approval of the Members of the Company. The draft Postal Ballot Notice along with the explanatory statement was approved to seek member approval for the increase in authorized share capital and the bonus issue through postal ballot by way of remote e-voting. The Board also appointed Central Depository Systems Limited (CDSL) as the agency for providing remote e-voting facility for the Postal Ballot process.

Key Highlights

  • Aptus Pharma proposes to increase its authorized share capital from INR. 7,15,00,000/- to INR 25,00,00,000/-
  • The company recommends a 3:2 bonus issue of equity shares, subject to approval
  • A Postal Ballot Notice along with explanatory statement was approved for seeking member approval
  • The Board appointed Central Depository Systems Limited (CDSL) as the e-voting agency for the Postal Ballot process
APPL
Pharmaceuticals
Aptus Pharma Ltd

Price Impact